451 related articles for article (PubMed ID: 34176693)
1. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
2. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
3. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
4. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
[TBL] [Abstract][Full Text] [Related]
6. Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: A retrospective observational cohort analysis of 1400 patients with ultrasound screening.
Harrison-Brown M; Scholes C; Douglas SL; Farah SB; Kerr D; Kohan L
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020926790. PubMed ID: 32484038
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
Singh G; Prentice HA; Winston BA; Kroger EW
J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study.
Sidhu V; Badge H; Churches T; Maree Naylor J; Adie S; A Harris I
BMC Musculoskelet Disord; 2023 Aug; 24(1):629. PubMed ID: 37537580
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
11. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
[TBL] [Abstract][Full Text] [Related]
13. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
14. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
Sidhu VS; Graves SE; Buchbinder R; Naylor JM; Pratt NL; de Steiger RS; Chong BH; Ackerman IN; Adie S; Harris A; Hansen A; Cripps M; Lorimer M; Webb S; Clavisi O; Griffith EC; Anandan D; O'Donohue G; Kelly TL; Harris IA
BMJ Open; 2019 Nov; 9(11):e031657. PubMed ID: 31699735
[TBL] [Abstract][Full Text] [Related]
15. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
[TBL] [Abstract][Full Text] [Related]
16. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty.
Deng W; Huo L; Yuan Q; Huang D; Li Q; Tian W
BMC Musculoskelet Disord; 2021 Jul; 22(1):608. PubMed ID: 34229632
[TBL] [Abstract][Full Text] [Related]
19. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
Runner RP; Shau DN; Staley CA; Roberson JR
J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
Richardson SS; Schairer WW; Sculco PK; Bostrom MP
Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
